COVID: India's vaccination coverage exceeds 189.17 crore, says health ministry
India | May 01, 2022 14:30 ISTSimilarly, COVID precaution dose administration for the age group 18-59 yrs also started from April 10, 2022, onwards, it stated.
Similarly, COVID precaution dose administration for the age group 18-59 yrs also started from April 10, 2022, onwards, it stated.
Many Sputnik V recipients who had taken their second dose way back in July last year are unable to get the booster shot. The two doses of Sputnik V are administered at a gap of 21-30 days.
The people of the age group 15-18 years have been provided with 5,83,09,299 1st dose and 4,18,99,185 2nd dose of the coronavirus vaccine, said the ministry.
This development comes after the Subject Expert Committee discussed recommendations for the restricted emergency of Covaxin in children aged between 2-12 years.
As per the ministry, in the age group 15-18 years, 5,78,45,181 1st dose and 4,03,05,973 2nd dose have been administered.
The recommendation also includes fourth shots for those between 18–64 with moderate to severe immune deficiency, Sweden’s Public Health Agency said in a statement. "The goal is just as before to prevent serious illness and death from Covid19," Agency chief Karin Tegmark Wisell said.
Nearly 50 children in the 12-14 age group were administered vaccine doses at the Aamdara primary health centre on Mar 24, CMHO said.
The vaccination against COVID in the age group of 12-14 years started on Wednesday as the country observed National Vaccination Day, with Biological E's intramuscular vaccine Corbevax, two doses of which are to be administered 28 days apart.
Also, necessary changes will be carried out in the CoWIN portal, said National Health Mission director Santosh Shukla in a statement.
The vaccination campaign will also be extended to people having an immunocompromised system who were not eligible for the vaccine until now, Le Parisien reported.
Health Minister Dr Mansukh Mandaviya congratulated the nation on achieving this historic landmark milestone of 180 crore landmark.
The researchers found that among those at the highest risk for the most severe COVID-19 illness were patients who had a heart defect and another health condition, were 50 years and older, or were men.
Additionally, over 97 pc of India's adult population have also received their first dose of vaccine against COVID.
The condition, formally known as multisystem inflammatory syndrome in children, involves fever plus symptoms affecting at least 2 organs and often includes stomach pain, skin rash or bloodshot eyes. It’s a rare complication in kids who have had COVID-19, and very rarely affects adults.
"With the administration of over 46.82 lakh (46,82,662) vaccine doses in the last 24 hours, India's COVID-19 vaccination coverage has exceeded 172.29 Cr (1,72,29,47,688) as per provisional reports till 7 am today," the ministry said in a press release.
"There may be need for yet again another boost- in this case, a 4th-dose boost for an individual receiving mRNA- that could be based on age, as well as underlying conditions," Dr Fauci said.
The interim data of the efficacy trial from Russia has shown an efficacy of 65.4 per cent against COVID-19, 21 days after immunisation.
The researchers from Technical University of Munich (TUM) in Germany found that a total of three exposures to the viral spike protein lead to production of virus neutralising antibodies that are high in quantity as well as quality.
Health Minister Mansukh Mandaviya today informed that in just one month, about 65 pc of children aged 15-18 years received the 1st dose of the vaccine.
With proactive efforts of States/UTs, along with Govt of India, Centre has administered over 66.68 cr doses of COVID vaccine which is amongst the highest in the world.
Top News
Latest News
